Release #:812-187714-rl-1235735: Orthopedic Desig
Post# of 7805
(Total Views: 378)
Posted On: 02/24/2020 7:04:09 AM
Release #:812-187714-rl-1235735:
Orthopedic Design & Technology
BioElectronics Corporation
ActiPatch Achieves FDA Market Clearance
BioElectronics Corporation, the maker of non-invasive electroceutical devices, has obtained a new 510(k) clearance from the U.S. Food and Drug Administration (FDA). This over-the counter marketing clearance was granted for the drug free ActiPatch medical device, for the indication: “adjunctive treatment of musculoskeletal pain.”
The ActiPatch was already FDA-cleared for over-the-counter treatment of pain from knee osteoarthritis and plantar fasciitis (heel pain) in 2017. The latest clearance expands these indications to cover all musculoskeletal pain complaint ...
Click here to read the full story
2/24/2020 6:08:44 AM
Orthopedic Design & Technology
BioElectronics Corporation
ActiPatch Achieves FDA Market Clearance
BioElectronics Corporation, the maker of non-invasive electroceutical devices, has obtained a new 510(k) clearance from the U.S. Food and Drug Administration (FDA). This over-the counter marketing clearance was granted for the drug free ActiPatch medical device, for the indication: “adjunctive treatment of musculoskeletal pain.”
The ActiPatch was already FDA-cleared for over-the-counter treatment of pain from knee osteoarthritis and plantar fasciitis (heel pain) in 2017. The latest clearance expands these indications to cover all musculoskeletal pain complaint ...
Click here to read the full story
2/24/2020 6:08:44 AM
(2)
(0)BioElectronics Corporation (BIEL) Stock Research Links
Scroll down for more posts ▼